The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
Open accessAbstract
Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail, chromatin conformation, protein-DNA interaction, and even transcription. HDACs are also post-transcriptional modifiers that regulate the protein acetylation implicated in several pathophysiologic states. HDAC inhibitors have been highlighted as a novel category of anti-cancer drugs. To date, four HDAC inhibitors, Vorinostat, Romidepsin, Panobinostat, and Belinostat, have been approved by the United States Food and Drug Administration. Principally, these HDAC inhibitors are used for hematologic cancers in clinic with less severe side effects. Clinical trials are continuously expanding to address other types of cancer and also nonmalignant diseases. HDAC inhibition also results in beneficial outcomes in various types of neurodegenerative diseases, inflammation disorders, and cardiovascular diseases. In this review, we will briefly discuss 1) the roles of HDACs in the acquisition of a cancer's phenotype and the general outcome of the HDAC inhibitors in cancer, 2) the functional relevance of HDACs in cardiovascular diseases and the possible therapeutic implications of HDAC inhibitors in cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
HDAC2 negatively regulates memory formation and synaptic plasticity
Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., Nieland, T. J. F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009) · Nature · doi:10.1038/nature07925 · Cited by 1,644
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365
Recovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 845
Peinado, H., Ballestar, E., Esteller, M., & Cano, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.306-319.2004 · Cited by 763
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J.-E., Lee, S.-W., Moon, E.-J., Kim, H.-S., Lee, S.-K., Chung, H. Y., et al. (2001) · Nature Medicine · doi:10.1038/86507 · Cited by 731
Histone deacetylase inhibitors: Potential in cancer therapy
Marks, P. A., & Xu, W. ‐. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22185 · Cited by 712
Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility
Montgomery, R. L., Davis, C. A., Potthoff, M. J., Haberland, M., Fielitz, J., Qi, X., Hill, J. A., Richardson, J. A., & Olson, E. N. (2007) · Genes & Development · doi:10.1101/gad.1563807 · Cited by 712
Coiffier, B., Pro, B., Prince, H. M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Borchmann, P., Morschhauser, F., Wilhelm, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.4223 · Cited by 680
Whittaker, S. J., Demierre, M.-F., Kim, E. J., Rook, A. H., Lerner, A., Duvic, M., Scarisbrick, J., Reddy, S., Robak, T., Becker, J. C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9066 · Cited by 664
Chang, S., McKinsey, T. A., Zhang, C. L., Richardson, J. A., Hill, J. A., & Olson, E. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8467-8476.2004 · Cited by 613
Wilson, A. J., Byun, D.-S., Popova, N., Murray, L. B., L'Italien, K., Sowa, Y., Arango, D., Velcich, A., Augenlicht, L. H., & Mariadason, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510023200 · Cited by 575
Weaver, B. A., & Cleveland, D. W. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.002 · Cited by 557
Kim, H. J., Rowe, M., Ren, M., Hong, J.-S., Chen, P.-S., & Chuang, D.-M. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120188 · Cited by 557
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.-P., & Göttlicher, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00114-x · Cited by 525
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260501497 · Cited by 517
Vega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N., & McKinsey, T. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8374-8385.2004 · Cited by 511
Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer
Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2004) · The Prostate · doi:10.1002/pros.20022 · Cited by 509
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
Trivedi, C. M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., Floss, T., Goettlicher, M., Noppinger, P. R., Wurst, W., et al. (2007) · Nature Medicine · doi:10.1038/nm1552 · Cited by 468
Deroanne, C. F., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J.-M., Nusgens, B. V., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205108 · Cited by 400
Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy
Kong, Y., Tannous, P., Lu, G., Berenji, K., Rothermel, B. A., Olson, E. N., & Hill, J. A. (2006) · Circulation · doi:10.1161/circulationaha.106.625467 · Cited by 377
Kee, H. J., Sohn, I. S., Nam, K. I., Park, J. E., Qian, Y. R., Yin, Z., Ahn, Y., Jeong, M. H., Bang, Y.-J., Kim, N., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.559724 · Cited by 368
Qing, H., He, G., Ly, P. T. T., Fox, C. J., Staufenbiel, M., Cai, F., Zhang, Z., Wei, S., Sun, X., Chen, C.-H., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081588 · Cited by 364
Increased expression of histone deacetylase 2 is found in human gastric cancer
SONG, J., NOH, J. H., LEE, J. H., EUN, J. W., AHN, Y. M., KIM, S. Y., LEE, S. H., PARK, W. S., YOO, N. J., LEE, J. Y., et al. (2005) · APMIS · doi:10.1111/j.1600-0463.2005.apm_04.x · Cited by 346
Expression Profile of Histone Deacetylase 1 in Gastric Cancer Tissues
Choi, J., Kwon, H. J., Yoon, B., Kim, J., Han, S. U., Joo, H. J., & Kim, D. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02153.x · Cited by 346
Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc min mice
Myzak, M. C., Dashwood, W. M., Orner, G. A., Ho, E., & Dashwood, R. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4785fje · Cited by 344
Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation
Jeon, E.-J., Lee, K.-Y., Choi, N.-S., Lee, M.-H., Kim, H.-N., Jin, Y.-H., Ryoo, H.-M., Choi, J.-Y., Yoshida, M., Nishino, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512494200 · Cited by 343
Huang, B. H., Laban, M., Leung, C. H.-W., Lee, L., Lee, C. K., Salto-Tellez, M., Raju, G. C., & Hooi, S. C. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401567 · Cited by 337
Kook, H., Lepore, J. J., Gitler, A. D., Lu, M. M., Wing-Man Yung, W., Mackay, J., Zhou, R., Ferrari, V., Gruber, P., & Epstein, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19137 · Cited by 332
Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter
Westendorf, J. J., Zaidi, S. K., Cascino, J. E., Kahler, R., van Wijnen, A. J., Lian, J. B., Yoshida, M., Stein, G. S., & Li, X. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7982-7992.2002 · Cited by 324
Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*
Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Ando, Y., Mita, K., Hamaguchi, M., Hara, Y., Kobayashi, S., & Iwase, H. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-6001-1 · Cited by 305
HDAC6 Expression Is Correlated with Better Survival in Breast Cancer
Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Omoto, Y., Ando, Y., Mita, K., Hamaguchi, M., Hayashi, S.-I., & Iwase, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0455 · Cited by 293
Histone deacetylase inhibition reduces myocardial ischemia‐reperfusion injury in mice
Granger, A., Abdullah, I., Huebner, F., Stout, A., Wang, T., Huebner, T., Epstein, J. A., & Gruber, P. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-108548 · Cited by 273
Linggi, B., Müller-Tidow, C., van de Locht, L., Hu, M., Nip, J., Serve, H., Berdel, W. E., van der Reijden, B., Quelle, D. E., Rowley, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm726 · Cited by 258
Noh, H., Oh, E. Y., Seo, J. Y., Yu, M. R., Kim, Y. O., Ha, H., & Lee, H. B. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00086.2009 · Cited by 254
Inhibition of Hypertrophy Is a Good Therapeutic Strategy in Ventricular Pressure Overload
Schiattarella, G. G., & Hill, J. A. (2015) · Circulation · doi:10.1161/circulationaha.115.013894 · Cited by 250
Targeting tumor angiogenesis with histone deacetylase inhibitors
Ellis, L., Hammers, H., & Pili, R. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.012 · Cited by 232
Valproic Acid Inhibits Angiogenesis in Vitro and in Vivo
Michaelis, M., Michaelis, U. R., Fleming, I., Suhan, T., Cinatl, J., Blaheta, R. A., Hoffmann, K., Kotchetkov, R., Busse, R., Nau, H., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.520 · Cited by 227
Guo, W., Shan, B., Klingsberg, R. C., Qin, X., & Lasky, J. A. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00128.2009 · Cited by 218
Belinostat: First Global Approval
Poole, R. M. (2014) · Drugs · doi:10.1007/s40265-014-0275-8 · Cited by 216
HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
Geng, H., Harvey, C. T., Pittsenbarger, J., Liu, Q., Beer, T. M., Xue, C., & Qian, D. Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257055 · Cited by 197
Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin
Kaluza, D., Kroll, J., Gesierich, S., Yao, T., Boon, R. A., Hergenreider, E., Tjwa, M., Rössig, L., Seto, E., Augustin, H. G., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.298 · Cited by 196
Histone Deacetylase 7 Silencing Alters Endothelial Cell Migration, a Key Step in Angiogenesis
Mottet, D., Bellahcène, A., Pirotte, S., Waltregny, D., Deroanne, C., Lamour, V., Lidereau, R., & Castronovo, V. (2007) · Circulation Research · doi:10.1161/circresaha.107.149377 · Cited by 192
Halili, M. A., Andrews, M. R., Labzin, L. I., Schroder, K., Matthias, G., Cao, C., Lovelace, E., Reid, R. C., Le, G. T., Hume, D. A., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0509363 · Cited by 186
Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer
Park, C. (2011) · Oncology Reports · doi:10.3892/or.2011.1236 · Cited by 183
Cavasin, M. A., Demos-Davies, K., Horn, T. R., Walker, L. A., Lemon, D. D., Birdsey, N., Weiser-Evans, M. C. M., Harral, J., Irwin, D. C., Anwar, A., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.258426 · Cited by 175
Class II Histone Deacetylases Are Directly Recruited by BCL6 Transcriptional Repressor
Lemercier, C., Brocard, M.-P., Puvion-Dutilleul, F., Kao, H.-Y., Albagli, O., & Khochbin, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201736200 · Cited by 172
Gallo, P., Latronico, M. V. G., Gallo, P., Grimaldi, S., Borgia, F., Todaro, M., Jones, P., Gallinari, P., De Francesco, R., Ciliberto, G., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn215 · Cited by 170
Urbich, C., Rössig, L., Kaluza, D., Potente, M., Boeckel, J., Knau, A., Diehl, F., Geng, J.-G., Hofmann, W., Zeiher, A. M., et al. (2009) · Blood · doi:10.1182/blood-2009-01-196485 · Cited by 168
Development of histone deacetylase inhibitors for cancer treatment
Marchion, D. C., & Münster, P. N. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.583 · Cited by 165
Inhibition of histone deacetylase on ventricular remodeling in infarcted rats
Lee, T., Lin, M., & Chang, N. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00891.2006 · Cited by 154
Nasu, Y., Nishida, K., Miyazawa, S., Komiyama, T., Kadota, Y., Abe, N., Yoshida, A., Hirohata, S., Ohtsuka, A., & Ozaki, T. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.10.014 · Cited by 151
Zhao, T., Cheng, G., Zhang, L., TSENG, Y., & PADBURY, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.08.010 · Cited by 145
Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury
Marumo, T., Hishikawa, K., Yoshikawa, M., Hirahashi, J., Kawachi, S., & Fujita, T. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00400.2009 · Cited by 141
Findeisen, H. M., Gizard, F., Zhao, Y., 青华, Heywood, E. B., Jones, K. L., Cohn, D. M., & Bruemmer, D. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.221952 · Cited by 137
Activation of Histone Deacetylase 2 by Inducible Heat Shock Protein 70 in Cardiac Hypertrophy
Kee, H. J., Eom, G. H., Joung, H., Shin, S., Kim, J., Cho, Y. K., Choe, N., Sim, B., Jo, D., Jeong, M. H., et al. (2008) · Circulation Research · doi:10.1161/01.res.0000338570.27156.84 · Cited by 134
Self-citationSong, C., Zhu, S., Wu, C., & Kang, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.498758 · Cited by 133
Trivedi, C. M., Lu, M. M., Wang, Q., & Epstein, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803686200 · Cited by 128
Structure and activity of enzymes that remove histone modifications
Holbert, M. A., & Marmorstein, R. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.006 · Cited by 127
Hanson, J. E., La, H., Plise, E., Chen, Y.-H., Ding, X., Hanania, T., Sabath, E. V., Alexandrov, V., Brunner, D., Leahy, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069964 · Cited by 121
Wang, Z., Tsai, L., Munasinghe, J., Leng, Y., Fessler, E. B., Chibane, F. L., Leeds, P. R., & Chuang, D. (2012) · Stroke · doi:10.1161/strokeaha.112.652545 · Cited by 118
Lee, H., Lee, D.-Y., Cho, H., Kim, S.-Y., Iwasaki, Y., & Kim, I. K. (2013) · Circulation Research · doi:10.1161/circresaha.113.301071 · Cited by 117
Histone Deacetylase 7 Controls Endothelial Cell Growth Through Modulation of β-Catenin
Margariti, A., Zampetaki, A., Xiao, Q., Zhou, B., Karamariti, E., Martin, D., Yin, X., Mayr, M., Li, H., Zhang, Z., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.213165 · Cited by 117
Histone modifications silence the GATA transcription factor genes in ovarian cancer
Caslini, C., Capo‐chichi, C. D., Roland, I., Nicolas, É., Yeung, A. T., & Xx, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209533 · Cited by 115
Eom, G. H., Cho, Y. K., Ko, J., Shin, S., Choe, N., Kim, Y., Joung, H., Kim, H.-S., Nam, K. I., Kee, H. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.003665 · Cited by 111
Self-citationZhang, L., Qin, X., Zhao, Y., Fast, L. D., Zhuang, S., Liu, P. Y., Cheng, G., & Zhao, T. C. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189910 · Cited by 109
Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma
Oki, Y., Buglio, D., Fanale, M. A., Fayad, L., Copeland, A. R. M., Romaguera, J. E., Kwak, L. W., Pro, B., Faria, S. D. C., Neelapu, S. S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1906 · Cited by 108
Response to Crozatier and Ventura-Clapier.
Schiattarella, G. G., & Hill, J. A. (2015) · PubMed · Cited by 107
Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
Eom, G. H., & Kook, H. Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.012 · Cited by 101
Self-citationAnnicotte, J., Iankova, I., Miard, S., Fritz, V., Sarruf, D. A., Abella, A., Berthe, M.-L., Noël, D., Pillon, A., Iborra, F., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00605-06 · Cited by 100
Usui, T., Okada, M., Mizuno, W., Oda, M., Ide, N., Morita, T., Hara, Y., & Yamawaki, H. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01039.2011 · Cited by 99
Kee, H. J., & Kook, H. Y. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.022 · Cited by 98
Okamoto, H., Fujioka, Y., Takahashi, A., Takahashi, T., Taniguchi, T., Ishikawa, Y., & Yokoyama, M. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.183 · Cited by 97
Cho, Y. K., Eom, G. H., Kee, H. J., Kim, H.-S., Choi, W.-Y., Nam, K. I., Ma, J. S., & Kook, H. Y. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0580 · Cited by 97
Self-citationAlao, J. P., Stavropoulou, A. V., Lam, E. W. ‐., Coombes, R. C., & Vigushin, D. M. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-8 · Cited by 92
Histone deacetylase inhibitors: Anticancer compounds
Smith, K. T., & Workman, J. L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.008 · Cited by 90
Homeobox Protein Hop Functions in the Adult Cardiac Conduction System
Ismat, F. A., Zhang, M., Kook, H., Huang, B., Zhou, R., Ferrari, V. A., Epstein, J. A., & Patel, V. V. (2005) · Circulation Research · doi:10.1161/01.res.0000163108.47258.f3 · Cited by 86
Eom, G. H., Nam, Y. S., Oh, J. G., Choe, N., Min, H.-K., Yoo, E.-K., Kang, G., Nguyen, V. H., Min, J.-J., Kim, J.-K., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.303429 · Cited by 81
Self-citationLi, D., Xie, S., Ren, Y., Huo, L., Gao, J., Cui, D., Liu, M., & Zhou, J. (2011) · Protein & Cell · doi:10.1007/s13238-011-1015-4 · Cited by 79
Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials
Kim, S. H., Ahn, S.-H., Han, J., Lee, H. W., Lee, H. Y., Lee, Y., Kim, M. R., Kim, K. W., Kim, W. B., & Hong, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.149 · Cited by 77
Bieszczad, K. M., Bechay, K., Rusche, J. R., Jacques, V., Kudugunti, S. K., Miao, W., Weinberger, N. M., McGaugh, J. L., & Wood, M. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0914-15.2015 · Cited by 71
Cuadrado-Tejedor, M., Garcia-Barroso, C., Sanzhez-Arias, J., Mederos, S., Rabal, O., Ugarte, A., Franco, R., Pascual-Lucas, M., Segura, V., Perea, G., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0142-9 · Cited by 69
Inhibition of Histone Deacetylase-induced Myocardial Repair Is Mediated by c-kit in Infarcted Hearts
Zhang, L., Chen, B. Y., Zhao, Y., Dubielecka, P. M., Wei, L., Qin, G. J., Chin, Y. E., Wang, Y., & Zhao, T. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379115 · Cited by 69
Archer, S. Y., Johnson, J. E., Kim, H., Ma, Q., Mou, H., Vishnuvardhan, D., Meng, S., & Hodin, R. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00575.2004 · Cited by 69
Cashen, A. F., Juckett, M. B., Jumonville, A. J., Litzow, M. R., Flynn, P. J., Eckardt, J. R., LaPlant, B. R., Laumann, K. M., Erlichman, C., & DiPersio, J. F. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1240-1 · Cited by 63
Epigenetic consequences of AML1–ETO action at the human c‐FMS locus
Follows, G., Tagoh, H., Lefevre, P., Hodge, D., Morgan, G. J., & Bonifer, C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg250 · Cited by 60
Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 4
Kee, H. J., Kwon, J., Shin, S., Ahn, Y., Jeong, M. H., & Kook, H. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.07.001 · Cited by 55
Azechi, T., Kanehira, D., Kobayashi, T., Sudo, R., Nishimura, A., Sato, F., & Wachi, H. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.15826 · Cited by 50
Olaharski, A. J., Ji, Z., Woo, J.-Y., Lim, S., Hubbard, A., Zhang, L., & Smith, M. T. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl068 · Cited by 49
McGarry, L., Winnie, J. N., & Ozanne, B. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207687 · Cited by 43
Histone Deacetylase 2 Is Upregulated in Normal and Keloid Scars
O’Connor, E. J. F., Badshah, I. I., Addae, L. Y., Kundasamy, P., Thanabalasingam, S., Abioye, D., Soldin, M. G., & Shaw, T. J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.432 · Cited by 42
Genética y arritmias: aplicaciones diagnósticas y pronósticas
Monteforte, N., Napolitano, C., & Priori, S. G. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.10.008 · Cited by 39
Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression
Sachweh, M. C. C., Drummond, C. J., Higgins, M., Campbell, J., & Laı́n, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.61 · Cited by 38
Ramjiawan, A., Bagchi, R. A., Blant, A., Albak, L., Cavasin, M. A., Horn, T. R., McKinsey, T. A., & Czubryt, M. P. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00262.2012 · Cited by 27
The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel.
Kuwajima, A., Iwashita, J., Murata, J., & Abé, T. (2007) · PubMed · Cited by 26
HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers
Gemoll, T., Roblick, U. J., Szymczak, S., Braunschweig, T. A., Becker, S., Igl, B., Bruch, H., Ziegler, A., Hellman, U., Difilippantonio, M. J., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0628-3 · Cited by 22
Genetics and Arrhythmias: Diagnostic and Prognostic Applications
Monteforte, N., Napolitano, C., & Priori, S. G. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.10.010 · Cited by 19
Cited by
Hull, E. E., Montgomery, M. R., & Leyva, K. J. (2016) · BioMed Research International · doi:10.1155/2016/8797206 · Cited by 313
Wang, P., Gong, Q., Hu, J., Li, X., & Zhang, X. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01704 · Cited by 270
Yuille, S., Reichardt, N., Panda, S., Dunbar, H., & Mulder, I. E. (2018) · PLOS ONE · doi:10.1371/journal.pone.0201073 · Cited by 257
Anti-senescence compounds: A potential nutraceutical approach to healthy aging
Gurău, F., Baldoni, S., Prattichizzo, F., Espinosa, E., Amenta, F., Procopio, A. D., Albertini, M. C., Bonafè, M., & Olivieri, F. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.001 · Cited by 179
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
Sarkar, R., Banerjee, S., Amin, S. A., Adhikari, N., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112171 · Cited by 121
Metadata
- Authors
- Yoon, S., & Eom, G. H.
- Venue
- Chonnam Medical Journal
- Published
- 2016
- Volume
- 52
- Issue
- 1
- Pages
- 1
- ISSN
- 0377-9564 (ISSN-L)
- 2233-7385
- 2233-7393
- OpenAlex
- W2271364972
- Cited by
- 464
- References
- 100
- FWCI
- 18.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.